Rolf H. Henel, Director at SCICLONE PHARMACEUTICALS INC (SCLN), bought 600 shares at $1.81 ($1K) on 2007-11-20, disclosed to the SEC on 2007-11-23.
Open-market purchase of $1k SCLN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.81 | 100 | $181 | 16.4% |
| 2 | $1.85 | 500 | $925 | 83.6% |
| Total | $1.84 avg | 600 | $1K | 100% |
| Filing → |
| SCLN | SELL | 2008-01-02 | $20K | — | Filing → |